BENGALURU, India & BRIDGEWATER, N.J.-- (BUSINESS WIRE)--Apr 7, 2026-- ...
Also, there is an impact of inflammation and diet on spinal health. Inflammation and dietary factors significantly affect ...
On March 27, Tiger Woods was arrested for DUI after his Range Rover rolled over near his home in Florida. He blew 0.00. No alcohol. Authorities suspect medication — the pharmacological residue of a ...
Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Disc Medicine develops novel therapeutics targeting hematologic diseases, with a pipeline focused on red blood cell biology, heme biosynthesis, and iron homeostasis. The company operates a ...
Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. Adam Feuerstein is a senior ...
Disc Medicine is well-capitalized, with over $800M in cash, ensuring operational runway through 2029 regardless of bitopertin's launch success. Bitopertin’s NDA is submitted, aiming for accelerated ...
In this increasingly digital era, physical media has become a thing of the past in most circles. There is, however, sustained interest in such supposedly antiquated tech. Some examples of this include ...
ROCK HILL — It started as an effort to occupy some kids at a park in Fresno, California, in the late 1960s. Decades later, George Sappenfield has watched kids and adults enjoy the evolution of his ...
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results